Korean National Health Insurance Value Incentive Program: Achievements and Future Directions
2
조회
0
다운로드
5
인용
0
참고문헌
키워드
초록
Since the reformation of the National Health Insurance Act in 2000, the Health Insurance Review and Assessment Service (HIRA) in the Republic of Korea has performed quality assessments for healthcare providers. The HIRA Value Incentive Program (VIP), established in July 2007, provides incentives for excellent-quality institutions and disincentives for poorquality ones. The program is implemented based on data collected between July 2007 and December 2009. The goal of the VIP is to improve the overall quality of care and decrease the quality gaps among healthcare institutions. Thus far, the VIP has targeted acute myocardial infarction (AMI) and Caesarian section (C-section) care. The incentives and disincentives awarded to the hospitals by their composite quality scores of the AMI and C-section scores. The results of the VIP showed continuous and marked improvement in the composite quality scores of the AMI and C-section measures between 2007 and 2010. With the demonstrated success of the VIP project, the Ministry of Health and Welfare expanded the program in 2011 to include general hospitals. The HIRA VIP was deemed applicable to the Korean healthcare system,but before it can be expanded further, the program must overcome several major concerns, as follows: inclusion of resource use measures, rigorous evaluation of impact, application of the VIP to the changing payment system, and expansion of the VIP to primary care clinics.
Abstract
Since the reformation of the National Health Insurance Act in 2000, the Health Insurance Review and Assessment Service (HIRA) in the Republic of Korea has performed quality assessments for healthcare providers. The HIRA Value Incentive Program (VIP), established in July 2007, provides incentives for excellent-quality institutions and disincentives for poorquality ones. The program is implemented based on data collected between July 2007 and December 2009. The goal of the VIP is to improve the overall quality of care and decrease the quality gaps among healthcare institutions. Thus far, the VIP has targeted acute myocardial infarction (AMI) and Caesarian section (C-section) care. The incentives and disincentives awarded to the hospitals by their composite quality scores of the AMI and C-section scores. The results of the VIP showed continuous and marked improvement in the composite quality scores of the AMI and C-section measures between 2007 and 2010. With the demonstrated success of the VIP project, the Ministry of Health and Welfare expanded the program in 2011 to include general hospitals. The HIRA VIP was deemed applicable to the Korean healthcare system,but before it can be expanded further, the program must overcome several major concerns, as follows: inclusion of resource use measures, rigorous evaluation of impact, application of the VIP to the changing payment system, and expansion of the VIP to primary care clinics.
참고문헌 (16)
- Comprehensive quality report of National Health Insurance 2009, "Health Insurance Review and Assessment Service", Health Insurance Review and Assessment Service, 3~ (2010)
- Comprehensive quality report of National Health Insurance 2010, "Health Insurance Review and Assessment Service", Health Insurance Review and Assessment Service, 3~ (2011)
- Organisation for Economic Cooperation and Development, "Health at a glance 2011: OECD indicators, OECD publishing", pp.96~97 (2011), Organisation for Economic Co-operation and Development
- Antman EM, "ACC", AHA guidelines for the management of patients with ST-elevation myocardial infarction; A report of the American College of Cardiology, J Am Coll Cardiol, pp.2004, 44(3)[DOI]
- Spertus JA, "Challenges and opportunities in quantifying the quality of care for acute myocardial infarction: summary from the Acute Myocardial Infarction Working Group of the American Heart Association", American College of Cardiology First Scientific Forum on Quality of Care and Outcomes Research in Cardiovascular Disease and Stroke, 2003, pp.107(12), 1681~1691
- Keeley EC, "Primary angioplasty versus intravenous thrombolytic therapy for acute myocardial infarction: a quantitative review of 23 randomised trials", Lancet, 361(9351), pp.13~20 (2003)
- Boersma E, "Predictors of outcome in patients with acute coronary syndromes without persistent ST-segment elevation. Results from an international trial of 9461 patients", Circulation, 101(22), pp.2557~2567 (2000), The PURSUIT Investigators
- Marciniak TA, "Improving the quality of care for Medicare patients with acute myocardial infarction: results from the Cooperative Cardiovascular Project", JAMA, 279(17), pp.1351~1357 (1998)
- Baigent C, "ISIS-2: 10 year survival among patients with suspected acute myocardial infarction in randomised comparison of intravenous streptokinase, oral aspirin, both, or neither", BMJ, 316(7141), pp.1337~1343 (1998), The ISIS-2 (Second International Study of Infarct Survival) Collaborative Group
- Collaborative overview of randomised trials of antiplatelet therapy, "Prevention of death, myocardial infarction, and stroke by prolonged antiplatelet therapy in various categories of patients", BMJ, 308(6921), pp.81~106 (1994), Antiplatelet Trialists’ Collaboration
- Park JS, "Can cesarean section rate be used as a hospital-wide quality indicator in Korean hospitals?", Korean J Obstet Gynecol, 40(9), pp.1943~1953 (1997)
- Librero J, "Inter-hospital variations in caesarean sections. A risk adjusted comparison in the Valencia public hospitals", J Epidemiol Community Health, 54(8), pp.631~636 (2000)
- Joint Commission on Accreditation of Healthcare Organizations, "Framework for improving performance: a guide for nurse", pp.205~ (1994), Joint Commission on Accreditation of Healthcare Organizations
- Mann LI, "Modern indications for cesarean section", Am J Obstet Gynecol, 135(4), pp.437~441 (1979)
- Lee SI, "Inter-hospital comparison of cesarean section rates after risk adjustment", Korean J Prev Med, 34(4), pp.337~346 (2001)
- 이광수, "건강보험 청구명세서 자료를 이용한 제왕절개 분만율 위험도 보정의 효과", 예방의학회지, 38(2), pp.132~140 (2005), 대한예방의학회